Hiv protease inhibitors

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

PI

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Group of protease inhibitors that inhibit the viral protease of HI viruses and are used for the treatment of HIV infections.

Pharmacodynamics (Effect)This section has been translated automatically.

HIV protease is an enzyme that plays an essential role in the genesis of new HI viruses. The HIV protease catalyses the cleavage of precursor molecules, which is a prerequisite for the reproduction and spread of the HI virus. HIV protease inhibitors (see also protease inhibitors in general) are modelled on the viral protease and differ only minimally from their models in certain amino acid sequences. The inhibitors occupy the protease binding site on the substrate (precursor protein) and thus interfere with the further processes in protein formation. As a result, incorrect virus components are generated, which leads to an interruption of the replication cycle.

IndicationThis section has been translated automatically.

Therapy of HIV infections; preparations are prescribed in combination with other antiretroviral drugs (see below HAART).

Undesirable effectsThis section has been translated automatically.

S.u. HAART.

LiteratureThis section has been translated automatically.

  1. Eron JJ JR (2002) HIV-1 protease inhibitors. Clin Infect Dis 30: 160-170

Authors

Last updated on: 29.10.2020